Multivariate analysis of the parameters affecting the choice of surgical treatment for patients with localized renal cell carcinoma (RCC).

Complex kidney tumors, Indications to partial nephrectomy Nephrometry Organ-sparing management Renal-cell carcinoma

Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
01 Oct 2024
Historique:
received: 20 02 2024
revised: 21 08 2024
accepted: 14 09 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 2 10 2024
Statut: aheadofprint

Résumé

to determine the key factors affecting the surgical treatment selection for patients with localized Renal-Cell Carcinoma (RCC) based on clinical and nephrometry data. A retrospective cohort study to determine the key factors affecting the surgical treatment on a subset of patients with localized RCC (T1-T2) that underwent surgical treatment at primary investigational center from 2010 to 2017. Primary results were validated on the retrospective dataset of patients treated at high-volume referent center. Validation aimed to test applicability of the predictive model designed during primary analysis. To determine the relationship between the risks of radical or partial nephrectomy, the multivariate predictive modeling method was used. Based on the analysis, for polary and laterally located tumors, the risk of RN was conditioned only by remaining functioning parenchyma volume (RFPV). The average critical value of RFPV for polar lesions was = 58%; for lateral tumors = 67%. For medial location, the risk of RN only depended on the tumor size. Average critical value of the tumor size in the medial location was = 38mm. Based on the ROC curve comparison, there were no statistically significant differences between the predictive models containing 12 and 3 factors (AUC For the polar and lateral tumor locations, the functioning parenchymal volumes of over 58 and 67% respectively serve as PN indications. However, for the medial lesions, the primary PN indication is a tumor size less than 38 mm.

Identifiants

pubmed: 39358102
pii: S1078-1439(24)00660-4
doi: 10.1016/j.urolonc.2024.09.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no conflict of interests to declare.

Auteurs

Maksym Pikul (M)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine; Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany. Electronic address: urogenetics@gmail.com.

Oleg Voylenko (O)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Oleksandr Stakhovskyi (O)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Sofiya Semko (S)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine; Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany.

Iurii Vitruk (I)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Oleksii Kononenko (O)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Bohdan Hrechko (B)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Andrii Tymoshenko (A)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Pia Paffenholz (P)

Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany.

David Pfister (D)

Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany.

Christian Bach (C)

Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany.

Constantin Rieger (C)

Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany.

Eduard Stakhovsky (E)

Department of Plastic and Reconstructive Oncourology, National Cancer Institute of Ukraine, Kyiv, Ukraine.

Axel Heidenreich (A)

Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany.

Classifications MeSH